Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
Rang in aandelen #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Aandeelprijs
$0.69158324
Marktkapitalisatie
$9.84M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-84.27%
Land
JP
Handel Delta-Fly Pharma, Inc. (4598)

Categorie

Koersgeschiedenis voor Delta-Fly Pharma, Inc. (4598)
Hoogste slotkoers: $0.69 op 2026-08-01

Laagste slotkoers: $3.99 op 2024-07-01
Koersgeschiedenis van Delta-Fly Pharma, Inc. van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -37.77%
2025 -13.51%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$736.64 6.99%
CH
$1.05K -7.40%
KR
$255.50 12.02%
BE